Sanofi Acquires Vigil to Boost Alzheimer’s Drug Pipeline
Sanofi took a bold step in the neuroscience sector on August 6, 2025, by acquiring Vigil Neuroscience, a U.S.-based biotechnology company. This acquisition aligns with Sanofi’s strategy to build a…